Neuroreport, 2014 · DOI: 10.1097/WNR.0000000000000249 · Published: October 22, 2014
Astrocytes, brain cells, react to injury in multiple sclerosis (MS). While they don't usually have Nav1.5 sodium channels, these appear in MS lesions. The study explores how Nav1.5 expression changes over time in mice with MS-like conditions. The study examined mice with conditions similar to MS, observing astrocytes to see if Nav1.5 expression correlated with disease severity or relapse/remission phases. Results showed Nav1.5 increased in astrocytes with worsening disease. In mice experiencing relapses and remissions, Nav1.5 levels in astrocytes rose during relapses and decreased during remissions. This suggests Nav1.5 plays a role in how astrocytes respond to inflammation in the brain.
Nav1.5 may be a potential therapeutic target to modulate reactive astrogliosis in vivo.
Understanding the temporal dynamics of Nav1.5 expression can provide insights into the role of astrocytes in the progression of MS.
Attenuation of reactive astrogliosis could contribute to the improved outcomes seen with sodium channel blockade.